Immunotherapy and Transarterial Radioembolization Combination Treatment for Advanced Hepatocellular Carcinoma

1Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California, USA;

2Division of General Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA;

3Biostatistics and Bioinformatics Research Center, Cedars-Sinai Medical Center, Los Angeles, California, USA;

4Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA;

5Division of Interventional Radiology, Cedars-Sinai Medical Center, Los Angeles, California, USA;

6Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, California, USA;

7Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA;

8Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

9Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA;

10Division of Digestive and Liver Diseases, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA;

11Department of Population & Data Sciences, UT Southwestern Medical Center, Dallas, Texas, USA.

Correspondence: Ju Dong Yang, MD. E-mail: [email protected].

SUPPLEMENTARY MATERIAL accompanies this paper at https://links.lww.com/AJG/D17

*Yee Hui Yeo, Jeff Liang contributed equally to this work.

Comments (0)

No login
gif